References
- R. H. Richey, U. U. Shah, M. Peak, J. V. Craig, J. L. Ford, C. E. Barker, A. J. Nunn and M. A. Turner, Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence, BMC Pediatr. 13 (2013) Article ID 81 (8 pages); https://doi.org/10.1186/1471-2431-13-81
- M. Preis, Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use, AAPS PharmSciTech 16 (2015) 234–241; https://doi.org/10.1208/s12249-015-0313-1
- V. M. Vaz and L. Kumar, 3D printing as a promising tool in personalized medicine, AAPS Pharm-SciTech 22 (2021) Article ID 49 (20 pages); https://doi.org/10.1208/s12249-020-01905-8
- C. Watson, E. A. Webb, S. Kerr, J. H. Davies, H. Stirling and H. Batchelor, How close is the dose? Manipulation of 10 mg hydrocortisone tablets to provide appropriate doses to children, Int. J. Pharm. 545 (2018) 57–63; https://doi.org/10.1016/j.ijpharm.2018.04.054
- C. Verrue, E. Mehuys, K. Boussery, J.-P. Remon and M. Petrovic, Tablet-splitting: a common yet not so innocent practice, J. Adv. Nurs. 67 (2011) 26–32; https://doi.org/10.1111/j.1365-2648.2010.05477.x
- T. B. Ernest, J. Craig, A. Nunn, S. Salunke, C. Tuleu, J. Breitkreutz, R. Alex and J. Hempenstall, Preparation of medicines for children – a hierarchy of classification, Int. J. Pharm. 435 (2012) 124–130; https://doi.org/10.1016/j.ijpharm.2012.05.070
- C. Litalien, S. Bérubé, C. Tuleu, A. Gilpin, É. K. Landry, M. Valentin, R. Strickley and M. A. Turner, From paediatric formulations development to access: Advances made and remaining challenges, Br. J. Clin. Pharmacol. 88 (2022) 4349–4383; https://doi.org/10.1111/bcp.15293
- V. Bhatt-Mehta, R. B. MacArthur, R. Löbenberg, J. J. Cies, I. Cernak and R. H. P. Ii, An algorithm to identify compounded non-sterile products that can be formulated on a commercial scale or imported to promote safer medication use in children, Pharm. Basel Switz. 3 (2015) 284–294; https://doi.org/10.3390/pharmacy3040284
- E. Rawlence, A. Lowey, S. Tomlin and V. Auyeung, Is the provision of paediatric oral liquid unlicensed medicines safe?, Arch. Dis. Child. - Educ. Amp Pract. Ed. 103 (2018) Article ID 310 (5 pages); https://doi.org/10.1136/archdischild-2016-312132
- J. M. Rood, M. J. Engels, S. L. Ciarkowski, L. D. Wagenknecht, C. J. Dickinson and J. G. Stevenson, Variability in compounding of oral liquids for pediatric patients: a patient safety concern, J. Am. Pharm. Assoc. JAPhA 54 (2014) 383–389; https://doi.org/10.1331/JAPhA.2014.13074
- D. A. van Riet-Nales, E. G. A. W. Römkens, A. Saint-Raymond, P. Kozarewicz, A. F. A. M. Schobben, T. C. G. Egberts and C. M. A. Rademaker, Oral medicines for children in the European paediatric investigation plans, PloS One 9 (2014) e98348 (8 pages); https://doi.org/10.1371/journal.pone.0098348
- E. Finney, Make medicine child size, Children’s medicines: A situational analysis, 2011; https://www.who.int/childmedicines/progress/CM_analysis.pdf; last access date March 29, 2023.
- European Medicines Agency, Guideline on pharmaceutical development of medicines for paediatric use, 2013; https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf; last access date March 29, 2023.
- J. Zisowsky, A. Krause and J. Dingemanse, Drug development for pediatric populations: Regulatory aspects, Pharmaceutics 2 (2010) 364–388; https://doi.org/10.3390/pharmaceutics2040364
- European Commission, State of Paediatric Medicines in the EU: 10 years of the EU Paediatric Regulation, 2017; https://health.ec.europa.eu/system/files/2017-11/2017_childrensmedicines_report_en_0.pdf; last access date July 4, 2023.
- M. Moreira and M. Sarraguça, How can oral paediatric formulations be improved? A challenge for the XXI century, Int. J. Pharm. 590 (2020) Article ID 119905 (9 pages); https://doi.org/10.1016/j.ijpharm.2020.119905
- K. A. Mfoafo, M. Omidian, C. D. Bertol, Y. Omidi and H. Omidian, Neonatal and pediatric oral drug delivery: Hopes and hurdles, Int. J. Pharm. 597 (2021) Article ID 120296 (12 pages); https://doi.org/10.1016/j.ijpharm.2021.120296
- R. G. Strickley, Q. Iwata, S. Wu and T. C. Dahl, Pediatric drugs – a review of commercially available oral formulations, J. Pharm. Sci. 97 (2008) 1731–1774; https://doi.org/10.1002/jps.21101
- Batchelor H, Paediatric Development: Anatomy. Age, Weight, Body Surface and Stature, Organ Development, Springer, New York 2014, pp. 3–7.
- F. Lopez, P. Mistry, H. Batchelor, J. Bennett, A. Coupe, T. Ernest, M. Orlu and C. Tuleu, Acceptability of placebo multiparticulate formulations in children and adults, Sci. Rep. 8 (2018) Article ID 9210 (10 pages); https://doi.org/10.1038/s41598-018-27446-6
- R. G. Strickley, Pediatric oral formulations: An updated review of commercially available pediatric oral formulations since 2007, J. Pharm. Sci. 108 (2019) 1335–1365; https://doi.org/10.1016/j.xphs.2018.11.013
- T. Simšič, B. Nolimal, J. Minova, A. Baumgartner and O. Planinšek, A straw for paediatrics: How to administer highly dosed, bitter tasting paracetamol granules, Int. J. Pharm. 602 (2021) Article ID 120615 (11 pages); https://doi.org/10.1016/j.ijpharm.2021.120615
- A. Hejduk and J. Lulek, Dispensing of minitablets – Has the problem been resolved?, Int. J. Pharm. 619 (2022) Article ID 121666 (16 pages); https://doi.org/10.1016/j.ijpharm.2022.121666
- Overview of taste masking excipients & technologies for solid & liquid oral pharmaceuticals offered by leading contract manufacturers (CDMOs, CMOs); https://www.pharmacompass.com/pharma-blog/overview-of-taste-masking-excipients-technologies-for-solid-liquid-oral-pharmaceuticals-offered-by-leading-contract-manufacturers-cdmos-cmos; last access date July 7, 2023.
- H. K. Batchelor and J. F. Marriott, Formulations for children: problems and solutions, Br. J. Clin. Pharmacol. 79 (2015) 405–418; https://doi.org/10.1111/bcp.12268
- Sympfiny®: Delivery device for multiparticulate drugs; https://www.cphi-online.com/sympfiny-delivery-device-for-multiparticulate-prod500849.html; last access date June 20, 2023.
- Unique minitablet dispenser meets flexible oral dosing need; https://www.ondrugdelivery.com/unique-minitablet-dispenser-meets-flexible-oral-dosing-need/; last access date June 20, 2023.
- IQ-Dose for micro-tablets dosage wins Award; http://www.industry24h.com/iq-dose-for-micro-tablets-dosage-wins-award/; last access date June 20, 2023.
- Zalviso®; https://www.red-dot.org/project/zalvisor-1-11418; last access date June 20, 2023.
- K. Wening, E. J. Laukamp, M. Thommes and J. Breitkreutz, Individual oral therapy with immediate release and effervescent formulations delivered by the solid dosage pen, J. Pers. Med. 2 (2012) 217–231; https://doi.org/10.3390/jpm2040217
- J. Schomakers, A. Grummel, Dosing Stick Containing Rod-shaped Tablets, U.S. Pat. 0178218A1, 16 Sept 2004.
- J. Walsh, A. Cram, K. Woertz, J. Breitkreutz, G. Winzenburg, R. Turner and C. Tuleu, Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients, Adv. Drug Deliv. Rev. 73 (2014) 14–33; https://doi.org/10.1016/j.addr.2014.02.012
- W. Faisal, F. Farag, A. A. H. Abdellatif and A. Abbas, Taste masking approaches for medicines, Curr. Drug Deliv. 15 (2018) 167–185; https://doi.org/10.2174/1567201814666171013145958
- S. Joshi and H.-U. Petereit, Film coatings for taste masking and moisture protection, Int. J. Pharm. 457 (2013) 395–406; https://doi.org/10.1016/j.ijpharm.2013.10.021
- X. Zheng, F. Wu, Y. Hong, L. Shen, X. Lin and Y. Feng, Developments in taste-masking techniques for traditional chinese medicines, Pharmaceutics 10 (2018); Article ID 157 (22 pages); https://doi.org/10.3390/pharmaceutics10030157
- K. Al-Japairai, S. Hamed Almurisi, A. Almonem Doolaanea, S. Mahmood, F. Alheibshy, A. Alobaida, N. Abdul-Halim and B. Chatterjee, A review on taste masked multiparticulate dosage forms for paediatric, Int. J. Pharm. 632 (2022) Article ID 122571 (16 pages); https://doi.org/10.1016/j.ijpharm.2022.122571
- H. Sohi, Y. Sultana and R. K. Khar, Taste masking technologies in oral pharmaceuticals: Recent developments and approaches, Drug Dev. Ind. Pharm. 30 (2004) 429–448; https://doi.org/10.1081/DDC-120037477
- D. Andrews, S. Salunke, A. Cram, J. Bennett, R. S. Ives, A. W. Basit and C. Tuleu, Bitter-blockers as a taste masking strategy: A systematic review towards their utility in pharmaceuticals, Eur. J. Pharm. Biopharm. 158 (2021) 35–51; https://doi.org/10.1016/j.ejpb.2020.10.017
- L. A. Felton, Use of polymers for taste-masking pediatric drug products, Drug Dev. Ind. Pharm. 44 (2018) 1049–1055; https://doi.org/10.1080/03639045.2018.1430822
- M. Guhmann, M. Preis, F. Gerber, N. Pöllinger, J. Breitkreutz and W. Weitschies, Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations, Drug Dev. Ind. Pharm. 41 (2015) 540–551; https://doi.org/10.3109/03639045.2014.884122
- Y. Nakano, A. Maeda, S. Uchida and N. Namiki, Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets, Int. J. Pharm. 446 (2013) 160–165; https://doi.org/10.1016/j.ijpharm.2013.02.019
- M. Drašković, D. Medarević, I. Aleksić and J. Parojčić, In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets, Drug Dev. Ind. Pharm. 43 (2017) 723–731; https://doi.org/10.1080/03639045.2016.1220572
- D. Douroumis, Practical approaches of taste masking technologies in oral solid forms, Expert Opin. Drug Deliv. 4 (2007) 417–426; https://doi.org/10.1517/17425247.4.4.417
- V. Jannin and Y. Cuppok, Hot-melt coating with lipid excipients, Prog. Film Coat. 457 (2013) 480–487; https://doi.org/10.1016/j.ijpharm.2012.10.026
- SPI Pharma, Actimask®: Taste Masked Actives, 2017; https://www.spipharma.com/media/2860/acti-mask-psb-oct-2017.pdf; last access date July 14, 2023.
- Z. Worku, V. Puri, L. Kumar and A. Bansal, Trends in pharmaceutical taste masking technologies: A patent review, Recent Pat. Drug Deliv. Formul. 3 (2009) 26–39; https://doi.org/10.2174/187221109787158364
- Evonik Industries, EUDRAGIT: Application Guidelines, 13th ed, Evonik Nutrition & Care GmbH, Germany 2019.
- European Medicines Agency, Cyclodextrins used as excipients, 2017; https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-cyclodextrins-used-excipients-medicinal-products-human-use_en.pdf; last access date February 3, 2023.
- M. S. S. Cunha-Filho, B. Dacunha-Marinho, J. J. Torres-Labandeira, R. Martínez-Pacheco and M. Landin, Characterization of β-lapachone and methylated β-cyclodextrin solid-state systems, AAPS PharmSciTech 8(3) (2007) Article ID 60 (10 pages); https://doi.org/10.1208/pt0803060
- N. E. Nasr, A. N. ElMeshad and A. R. Fares, Nanocarrier systems in taste masking, Sci. Pharm. 90 (2022) Artile ID 20 (14 pages); https://doi.org/10.3390/scipharm90010020
- B. Al-kasmi, MHD. B. Alsirawan, M. Bashimam and H. El-zein, Mechanical microencapsulation: The best technique in taste masking for the manufacturing scale – Effect of polymer encapsulation on drug targeting, J. Controll. Release 260 (2017) 134–141; https://doi.org/10.1016/j.jconrel.2017.06.002
- D. Bar-Shalom, Necessity of rethinking oral pediatric formulations, Clin. Ther. 36 (2014) 180–183; https://doi.org/10.1016/j.clinthera.2014.01.010
- M. Ghimire, Z. N. Mahmoudi, J. Teckoe and A. Rajabi-Siahboomi, Application of a pH dependent taste-mask film coating for pediatric multiparticulate formulations, Int. J. Pharm. 536 (2018) 490–522; https://doi.org/10.1016/j.ijpharm.2017.08.021
- M. Jelvehgari, L. Barghi and F. Barghi, Preparation of chlorpheniramine maleate-loaded alginate/chitosan particulate systems by the ionic gelation method for taste masking, Jundishapur J. Nat. Pharm. Prod. 9 (2014) 39–48; https://doi.org/10.17795/jjnpp-12530
- M. Münster, C. Schoch, C. Schmidt and J. Breitkreutz, Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel, Eur. J. Pharm. Sci. 109 (2017) 446–454; https://doi.org/10.1016/j.ejps.2017.08.034
- E. Combescot, G. Morat, P. de Lonlay and V. Boudy, Pediatric drug formulation of sodium benzoate extended-release granules, Pharm. Dev. Technol. 21 (2016) 261–267; https://doi.org/10.3109/10837450.2014.996898
- T. Yoshida, H. Tasaki, A. Maeda, M. Katsuma, K. Sako and T. Uchida, Salting-out taste-masking system generates lag time with subsequent immediate release, Int. J. Pharm. 365 (2009) 81–88; https://doi.org/10.1016/j.ijpharm.2008.08.026
- B. Albertini, C. Cavallari, N. Passerini, D. Voinovich, M. L. González-Rodrýìguez, L. Magarotto and L. Rodriguez, Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer, Eur. J. Pharm. Sci. 21 (2004) 295–303; https://doi.org/10.1016/j.ejps.2003.10.017
- D. D. Douroumis, A. Gryczke and S. Schminke, Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets, AAPS PharmSciTech 12 (2011) 141–151; https://doi.org/10.1208/s12249-010-9569-7
- S. L. Cantor, M. A. Khan and A. Gupta, Development and optimization of taste-masked orally dis-integrating tablets (ODTs) of clindamycin hydrochloride, Drug Dev. Ind. Pharm. 41 (2015) 1156–1164; https://doi.org/10.3109/03639045.2014.935392
- A. Alayoubi, B. Daihom, H. Adhikari, S. Mishra, R. Helms and H. Almoazen, Development of a taste-masked oral suspension of clindamycin HCl using ion exchange resin Amberlite IRP 69 for use in pediatrics, Drug Dev. Ind. Pharm. 42 (2016) 1579–1589; https://doi.org/10.3109/03639045.2016.1160102
- H. Lou, M. Liu, L. Wang, S. R. Mishra, W. Qu, J. Johnson, E. Brunson and H. Almoazen, Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric use, AAPS Pharm-SciTech 14 (2013) 950–958; https://doi.org/10.1208/s12249-013-9981-x
- M. F. Al-Omran, S. A. Al-Suwayeh, A. M. El-Helw and S. I. Saleh, Taste masking of diclofenac sodium using microencapsulation, J. Microencapsul. 19 (2002) 45–52; https://doi.org/10.1080/02652040110055612
- P. S. Sona and C. Muthulingam, Formulation and evaluation of taste masked orally disitegrating tablets of diclofenac sodium, Int. J. PharmTech Res. 3 (2011) 819–826; https://doi.org/10.1081/DDC-120037477
- S. Yıldız, E. Aytekin, B. Yavuz, S. Bozdağ Pehlivan, İ. Vural and N. Ünlü, Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules, Pharm. Dev. Technol. 23 (2018) 488–495; https://doi.org/10.1080/10837450.2017.1315670
- P. Shrestha, R. Shrestha and S. Shrestha, Formulation and evaluation of orally disintegrating tablet containing taste masked mirtazapine, Pharm. Res. 10(2) (2021) 71–80; https://doi.org/10.15406/japlr.2021.10.00368
- B. S. Silva, M. Santangelo, M.-J. Colbert, C. Fauteux-Lefebvre, J. A. Bartlett, P.-P. Lapointe-Garant and R. Gosselin, Building process understanding of fluid bed taste mask coating of microspheres, AAPS PharmSciTech 20 (2019) Article ID 173 (14 pages); https://doi.org/10.1208/s12249-019-1384-1
- P. C. Kayumba, N. Huyghebaert, C. Cordella, J. D. Ntawukuliryayo, C. Vervaet and J. P. Remon, Quinine sulphate pellets for flexible pediatric drug dosing: Formulation development and evaluation of taste-masking efficiency using the electronic tongue, Eur. J. Pharm. Biopharm. 66 (2007) 460–465; https://doi.org/10.1016/j.ejpb.2006.11.018
- V. Patravale and N. B. Prabhu, Taste masking of quinine sulphate, Ind. J. Pharm. Sci. 67 (2005) 233–235.
- A. Keeley, M. Teo, Z. Ali, J. Frost, M. Ghimire, A. Rajabi-Siahboomi, M. Orlu and C. Tuleu, In vitro dissolution model can predict the in vivo taste masking performance of coated multiparticulates, Mol. Pharm. 16 (2019) 2095–2105; https://doi.org/10.1021/acs.molpharmaceut.9b00060
- U. Stange, C. Führling and H. Gieseler, Taste masking of naproxen sodium granules by fluid-bed coating, Pharm. Dev. Technol. 19 (2014) 137–147; https://doi.org/10.3109/10837450.2012.757784
- X. Hu, Y. Li, E. Zhang, X. Wang, M. Xing, Q. Wang, J. Lei and H. Huang, Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride, AAPS PharmSciTech 14 (2013) 29–37; https://doi.org/10.1208/s12249-012-9880-6
- H. F. Alotaibi, S. Elsamaligy, G. M. Mahrous, M. A. Bayomi and H. A. Mahmoud, Design of taste masked enteric orodispersible tablets of diclofenac sodium by applying fluid bed coating technology, Saudi Pharm. J. 27 (2019) 354–362; https://doi.org/10.1016/j.jsps.2018.12.003
- Y. Chen, Y. Liu, C. Wu, X. Pan and T. Peng, Dry suspension containing coated pellets with pH-dependent drug release behavior for the taste-masking of azithromycin, AAPS PharmSciTech 24 (2022) Article ID 21 (9 pages); https://doi.org/10.1208/s12249-022-02484-6
- R. Huang, Y. Zhang, T. Wang, L. Shen, Z. Zhang, Y. Wang and D. Quan, Creation of an assessment system for measuring the bitterness of azithromycin-containing reverse micelles, Asian J. Pharm. Sci. 13 (2018) 343–352; https://doi.org/10.1016/j.ajps.2018.02.001
- N. Choudhary and J. Avari, Formulation and evaluation of taste mask pellets of granisetron hydro-chloride as oro dispersible tablet, Braz. J. Pharm. Sci. 51 (2015) 569–578; https://doi.org/10.1590/S1984-82502015000300009
- T. Hamashita, M. Matsuzaki, T. Ono, M. Ono, Y. Tsunenari, T. Aketo and S. Watano, Granulation of core particles suitable for film coating by agitation fluidized bed ii. A proposal of a rapid dissolution test for evaluation of bitter taste of ibuprofen, Chem. Pharm. Bull. (Tokyo) 56 (2008) 883–887; https://doi.org/10.1248/cpb.56.883
- T. Hamashita, Y. Nakagawa, T. Aketo and S. Watano, Granulation of core particles suitable for film coating by agitation fluidized bed I. Optimum formulation for core particles and development of a novel friability test method, Chem. Pharm. Bull. (Tokyo) 55 (2007) 1169–1174; https://doi.org/10.1248/cpb.55.1169
- BASF, Kollicoat® Smartseal 100 P: Technical Information, 2019; https://www.pharmaexcipients.com/product/kollicoat-smartseal-100-p/; last access date June 27, 2023.
- BASF, Kollicoat® Smartseal 30 D: Technical Information, 2019; https://www.pharmaexcipients.com/product/kollicoat-smartseal-30-d/; last access date June 27, 2023.
- Eudragit® E 100, Eudragit® E PO and Eudragit® E 12,5; https://www.pharmaexcipients.com/news/eudragit-e-100-12-5-po/; last access date June 2, 2023.
- Eudragit L 30 D-55; https://www.pharmaexcipients.com/product/eudragit-l-30-d-55/; last access date June 2, 2023.
- Eudragit brochure; https://www.pharmaexcipients.com/product/eudragit-l-30-d-55/?attachment_id=201953&download_file=grhphtodbu688; last access date June 2, 2023.
- Evonik EUDRAGIT® RL 30 D Copolymer; https://www.matweb.com/search/datasheettext.aspx?matguid=97322e67e21c46f4950bd8b64f71c82d; last access date June 2, 2023.
- H. Lim and S. W. Hoag, Plasticizer effects on physical-mechanical properties of solvent cast Soluplus® films, AAPS PharmSciTech 14 (2013) 903–910; https://doi.org/10.1208/s12249-013-9971-z
- A. Roy, A. Ghosh, S. Datta, S. Das, P. Mohanraj, J. Deb and M. E. Bhanoji Rao, Effects of plasticizers and surfactants on the film forming properties of hydroxypropyl methylcellulose for the coating of diclofenac sodium tablets, Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc. 17 (2009) 233–241; https://doi.org/10.1016/j.jsps.2009.08.004
- L. A. Felton and J. W. McGinity, Influence of insoluble excipients on film coating systems, Drug Dev. Ind. Pharm. 28 (2002) 225–243; https://doi.org/10.1081/DDC-120002839
- M. Pein, M. Preis, C. Eckert and F. E. Kiene, Taste-masking assessment of solid oral dosage forms – a critical review, Int. J. Pharm. 465 (2014) 239–254; https://doi.org/10.1016/j.ijpharm.2014.01.036
- S. Gittings, N. Turnbull, C. J. Roberts and P. Gershkovich, Dissolution methodology for taste masked oral dosage forms, J. Control. Release 173 (2014) 32–42; https://doi.org/10.1016/j.jconrel.2013.10.030
- Y. Thabet, M. Slavkova and J. Breitkreutz, 10 years EU regulation of pediatric medicines – impact on cardiovascular drug formulations, Expert Opin. Drug Deliv. 15 (2018) 261–270; https://doi.org/10.1080/17425247.2018.1420054
- E. H. Davies and C. Tuleu, Medicines for children: A matter of taste, J. Pediatr. 153 (2008) 599–604.e2; https://doi.org/10.1016/j.jpeds.2008.06.030
- B. Al-Kasmi, O. Al Rahal, H. El-Zein and A.-H. Nattouf, Structural and in vitro in vivo evaluation for taste masking, Expert Opin. Drug Deliv. 15 (2018) 1105–1116; https://doi.org/10.1080/17425247.2018.1535590
- G. F. Petrovick, J. Breitkreutz and M. Pein-Hackelbusch, Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization, Int. J. Pharm. 506 (2016) 361–370; https://doi.org/10.1016/j.ijpharm.2016.04.058
- A. S. Alshetaili, B. K. Almutairy, R. V. Tiwari, J. T. Morott, S. M. Alshehri, X. Feng, B. B. Alsulays, J.-B. Park, F. Zhang and M. A. Repka, Preparation and evaluation of hot-melt extruded patient-centric ketoprofen mini-tablets, Curr. Drug Deliv. 13 (2016) 730–741; https://doi.org/10.2174/1567201812666151012113806
- G. F. Petrovick, P. Kleinebudde and J. Breitkreutz, Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties, Eur. J. Pharm. Biopharm. 122 (2018) 137–145; https://doi.org/10.1016/j.ejpb.2017.10.018
- C. Eckert, M. Pein and J. Breitkreutz, Lean production of taste improved lipidic sodium benzoate formulations, Eur. J. Pharm. Biopharm. 88 (2014) 455–461; https://doi.org/10.1016/j.ejpb.2014.05.013
- V. Kharb, V. A. Saharan, V. Kharb, H. Jadhav and S. Purohit, Formulation and evaluation of lipid based taste masked granules of ondansetron HCl, Eur. J. Pharm. Sci. 62 (2014) 180–188; https://doi.org/10.1016/j.ejps.2014.05.012
- D. G. Lopes, V. Garsuch, K. Becker, A. Paudel, M. Stehr, A. Zimmer and S. Salar-Behzadi, Improving the granule strength of roller-compacted ibuprofen sodium for hot-melt coating processing, Int. J. Pharm. 510 (2016) 285–295; https://doi.org/10.1016/j.ijpharm.2016.06.049
- R. Obaidat, H. Aleih, H. Mashaqbeh, B. Altaani, M. M. Alsmadi and M. Alnaief, Development and evaluation of cocoa butter taste masked ibuprofen using supercritical carbon dioxide, AAPS PharmSciTech 22 (2021) Article ID 106 (13 pages); https://doi.org/10.1208/s12249-021-01962-7
- Council of Europe, European Pharmacopoeia 10th Edition. Strasbourg 2019.
- M. Siewert, J. Dressman, C. K. Brown and V. P. Shah, FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms, AAPS PharmSciTech 4 (2003) Article ID E7 (10 pages); https://doi.org/10.1208/pt040107
- C. M. Khor, W. K. Ng, P. Kanaujia, K. P. Chan and Y. Dong, Hot-melt extrusion microencapsulation of quercetin for taste-masking, J. Microencapsul. 34 (2017) 29–37; https://doi.org/10.1080/02652048.2017.1280095